Skip to content

Resiliency Training on the College Campus

Resiliency Training on the College Campus

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06038786
Enrollment
107
Registered
2023-09-15
Start date
2018-07-01
Completion date
2020-03-01
Last updated
2023-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychotic Disorders, Mood Disorders, Anxiety Disorders

Brief summary

This is a waitlist controlled study examining the initial efficacy of Resilience Training among college students at an elevated risk for a severe mental illness.

Interventions

A 4 session group-based behavioral intervention which delivers the following skills: mindfulness, metallization, and self-compassion.

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Waitlist controlled design

Eligibility

Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
No

Inclusion criteria

1. 18-30 years old 2. Enrolled in undergraduate program at the college or university where the intervention takes place 3. Students who endorse delusion-like experiences (DLEs): Peter's et al. Delusion Inventory (PDI) score \> 4 and/or 4. Students with mild to moderate depressive symptoms: Beck Depression Inventory (BDI) score ≥ 6

Exclusion criteria

1. Inability to provide informed consent 2. Not proficient in English 3. Current self-reported Diagnostic Statistical Manual 5 (DSM-5) diagnosis with active symptoms (such as active psychotic symptoms, current suicidality, serious active alcohol or substance use, marked deterioration in functioning over the prior month) determined by clinical interview with participant, or self-report of a psychiatric diagnosis that necessitates close monitoring or individual therapy and/or inpatient or partial hospitalization 4. Current enrollment in psychological or behavioral health treatment. 5. Current use of psychotropic medications (other than stimulants) prescribed by a physician.

Design outcomes

Primary

MeasureTime frameDescription
Peters Delusions InventoryBaseline, 4-weeks, 12 monthsThe Peters Delusions Inventory (PDI) is a brief 21-item survey using non-stigmatizing and non-clinical language to obtain ratings of common delusional experiences (e.g. paranoia, grandiosity, ideas of reference) and perceptual aberrations (e.g. experiences of being controlled; thought insertion, withdrawal, and echoing). The PDI also captures conviction, preoccupation, and distress related to the delusions. This scale is scored from 0-21, with higher scores indicating more presence of these delusions.
Beck Depression InventoryBaseline, 4-weeks, 12 monthsThe Beck Depression Inventory (BDI) is a 21-item self-report assessment obtaining ratings of one's level of depression on a Likert scale of 0-63, with higher scores indicating more depressive symptoms.
Spielberger State-Trait Anxiety InventoryBaseline, 4-weeks, 12 monthsThe Spielberger State-Trait Anxiety Inventory (STAI) is a 20-item self-report scale obtaining ratings of one's anxiety, both those that are trait like and ongoing, and those that are state like and temporary. Scores range from 0-120, with higher scores indicate higher levels of anxiety symptoms.

Secondary

MeasureTime frameDescription
Connor-Davidson Resilience ScaleBaseline, 4-weeks, 12 monthsThe Connor-Davidson Resilience Scale (CD-RISC) is a 25-item self-report scale obtaining ratings of one's level of coping and emotional resilience. It is rated on a scale of 0-100, with higher scores indicate one has more coping skills and more emotional resilience.
Five Facet Mindfulness QuestionnaireBaseline, 4-weeks, 12 monthsThe Five Facet Mindfulness Questionnaire (FFMQ) is a 39-item self-report survey that obtains ratings of one's capacity for mindfulness. It contains 5 sub scales, although this study only used the total score. It is scored on a 0-195 scale, though a mean score is taken ranging from 0-5, with higher scores indicate greater capacity for mindfulness.
Interpersonal Reactivity IndexBaseline, 4-weeks, 12 monthsThe Interpersonal Reactivity Index (IRI) is a 28-item self-report scale that measures one's ability to experience empathy for another person. The scale has 4 sub scales, yet this study utilized only two of them: the empathic concern and perspective taking subscales. It is scored on a 0-140 scale, with higher ratings indicate more ability for empathy.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026